MONTREAL, April 25,
2022 /CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH)
(OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"),
a Canadian pharmaceutical company, announced today that
Steve Saviuk, Valeo's Chief
Executive Officer, will present a corporate overview and provide a
commercial update on key products of the Company at the 2022 Bloom
Burton & Co Healthcare Investor Conference.
Presentation Details:
Event: 2022 Bloom Burton & Co.
Healthcare Investor Conference
Date/Time: Tuesday, May 3,
2022 at 11:00 am ET
A live webcast of the presentation may be accessed via
https://wsw.com/webcast/bloomburton7/vph/2542156 and on the Webcast
& Events page under the Investors section of the Company's
website at Events - Valeo Pharma. Following the event, an archived
webcast will be available on the Company's website.
About the Conference:
The Bloom Burton & Co. Healthcare Investor Conference brings
together U.S., Canadian and international investors who are
interested in the latest developments in the Canadian healthcare
sector. Attendees will have an opportunity to obtain corporate
updates from the premier Canadian publicly traded and private
companies through presentations and private meetings.
About Valeo Pharma
Valeo Pharma is a pharmaceutical company dedicated to the
commercialization of innovative prescription products in
Canada with a focus on
Respirology, Neurodegenerative Diseases, Oncology and other
specialty products. Headquartered in Kirkland, Quebec, Valeo Pharma has the full
capability and complete infrastructure to register and properly
manage its growing product portfolio through all stages of
commercialization. For more information, please visit
www.valeopharma.com and follow us on LinkedIn and Twitter.
Forward Looking
Statements
This press release contains forward-looking statements about
Valeo's objectives, strategies and businesses that involve risks
and uncertainties. These statements are "forward-looking" because
they are based on our current expectations about the markets we
operate in and on various estimates and assumptions. Actual events
or results may differ materially from those anticipated in these
forward-looking statements if known or unknown risks affect our
business, or if our estimates or assumptions turn out to be
inaccurate.
SOURCE Valeo Pharma Inc.